Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Levothyroxine Sodium (H03Aa01) Within The Framework Of A So-Called Open-House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 97020027

  Document Type - Tender Notices

Description - Description: Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient levothyroxine sodium (H03AA01) within the period from January 1, 2025 to December 31, 2026 with the possibility of concluding the contract at any time (open-house model). In the open house procedure, medicinal products in accordance with the BfArM list in accordance with Section 35 Paragraph 5a SGB V (medicines for children) are excluded.local title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Levothyroxin-Natrium (H03AA01) im Rahmen

Gt Ref Id - 97020027

Deadline - Oct 31, 2026